Clinical status of long-acting local anesthetics for pain management in pediatric patients
CHEN Qian
ZHANG Gao-long
SONG Xing-rong
Abstract：Liposomal bupivacaine(LB)is a novel,long-acting local anesthetic that has attracted attention for its unique advantages in postoperative pain management.Compared with traditional bupivacaine,LB can provide continu-ous analgesia for up to 72 hours,reducing opioid consumption,which is particularly important for pediatric surgical pa-tients.With increasing concerns about opioid dependence and abuse,the use of LB in pediatric surgery has become a top-ic of interest.This article reviews recent literature on LB in pediatric surgery,analyzing its effects on pain control,opioid consumption,length of stay(LOS),safety,and adverse events,aiming to provide guidance for clinical application.
Keywords：long-acting local anestheticsliposomal bupivacainepediatricpain managementopioids
Publication Date：2025-10-15
Online Publishing Date：2025-11-28(First online date of this platform, not the publication date of the document)
Pages：5( 1464-1468 )